Empowered Patient

Optimizing Health System Resources for Patients Needing Acute Care with Niloy Sanyal LeanTaaS
Empowered Patient

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

  • CMS 2022 Changes for Medicare Advantage with Jessica Magana Lightbeam Health Solutions TRANSCRIPT
    on September 13, 2021 by Karen Jagoda

    Jessica Magana is the Product Manager of Lightbeam Health Solutions, a population health management company. Jessica shines a light on the biggest changes coming from CMS in risk adjustment for Medicare Advantage in 2022. Organizations need to understand the technical requirements behind the way diagnosed base risk scores will be calculated and the impact of delayed healthcare due to COVID-19. Jessica explains, "Lightbeam is a platform that facilitates end-to-end population health management for our ACOs, payers, provider groups, health systems, and some other healthcare organizations. Just some highlights about the platform and what it provides are provider alignment, tools for engagement, and satisfaction rates. It allows for some two-way information sharing. It has been proven to lower utilization rates and improve risk and coding opportunities; it also helps to improve quality scores for HEDIS and Star measures." "Another important change that I think is very important is around some of the quality bonus program changes. Due to COVID-19, a public health emergency has been awarded. CMS is now promoting some new changes that are going to impact some of those Star ratings." @LightbeamHealth #LightbeamHealth #assessment #caremanagement #Healthcare #HealthIT #Payer #PayerProvider #PopHealth #PopulationHealth #referral #VBC #MedicareAdvantage #MA #COVID19 Lightbeamhealth.com Listen to the podcast here

  • CMS 2022 Changes for Medicare Advantage with Jessica Magana Lightbeam Health Solutions
    on September 13, 2021 by Karen Jagoda

    Jessica Magana is the Product Manager of Lightbeam Health Solutions, a population health management company. Jessica shines a light on the biggest changes coming from CMS in risk adjustment for Medicare Advantage in 2022. Organizations need to understand the technical requirements behind the way diagnosed base risk scores will be calculated and the impact of delayed healthcare due to COVID-19. Jessica explains, "Lightbeam is a platform that facilitates end-to-end population health management for our ACOs, payers, provider groups, health systems, and some other healthcare organizations. Just some highlights about the platform and what it provides are provider alignment, tools for engagement, and satisfaction rates. It allows for some two-way information sharing. It has been proven to lower utilization rates and improve risk and coding opportunities; it also helps to improve quality scores for HEDIS and Star measures." "Another important change that I think is very important is around some of the quality bonus program changes. Due to COVID-19, a public health emergency has been awarded. CMS is now promoting some new changes that are going to impact some of those Star ratings." @LightbeamHealth #LightbeamHealth #assessment #caremanagement #Healthcare #HealthIT #Payer #PayerProvider #PopHealth #PopulationHealth #referral #VBC #MedicareAdvantage #MA #COVID19 Lightbeamhealth.com Download the transcript here

  • Treating Rare MPN Diseases Caused by Genetic Mutations in Blood Stem Cells with Dr. Hugh Rienhoff Imago BioSciences TRANSCRIPT
    on September 12, 2021 by Karen Jagoda

    Dr. Hugh Rienhoff is the Founder and Chief Executive Officer at Imago BioSciences.  He and his team are developing their lead asset bomedemstat for the treatment of myeloproliferative neoplasms (MPNs) which are rare blood cancers. Hugh explains, "So MPNs, myeloproliferative neoplasms, are actually a family of diseases that include myelofibrosis, polycythemia vera, and essential thrombocythemia. And they're all characterized by an elevation of one element in the blood or another different cell type." "But they're all related in the sense that they share a family of very limited mutations. And those mutations, in one of three genes, typically arise in patients who are in their 50s or 60s and those mutations occur in the blood stem cells." "They're not hereditary, typically. They're what we call somatic mutations arising in blood stem cells. And they are called neoplastic diseases, which is a Greek name for cancer, but they typically are much more indolent than your typical bone marrow cancers, like leukemia, which are almost fulminant by comparison." @Imagobiorx #ImagoBioSciences #MPN #MPNSM #EssentialThrombocythemia #myelofibrosis #bomedemstat #LSD1 #BloodCancer #RareDisease ImagoBio.com Listen to the podcast here    

  • Treating Rare MPN Diseases Caused by Genetic Mutations in Blood Stem Cells with Dr. Hugh Rienhoff Imago BioSciences
    on September 12, 2021 by Karen Jagoda

    Dr. Hugh Rienhoff is the Founder and Chief Executive Officer at Imago BioSciences.  He and his team are developing their lead asset bomedemstat for the treatment of myeloproliferative neoplasms (MPNs) which are rare blood cancers. Hugh explains, "So MPNs, myeloproliferative neoplasms, are actually a family of diseases that include myelofibrosis, polycythemia vera, and essential thrombocythemia. And they're all characterized by an elevation of one element in the blood or another different cell type." "But they're all related in the sense that they share a family of very limited mutations. And those mutations, in one of three genes, typically arise in patients who are in their 50s or 60s and those mutations occur in the blood stem cells." "They're not hereditary, typically. They're what we call somatic mutations arising in blood stem cells. And they are called neoplastic diseases, which is a Greek name for cancer, but they typically are much more indolent than your typical bone marrow cancers, like leukemia, which are almost fulminant by comparison." @Imagobiorx #ImagoBioSciences #MPN #MPNSM #EssentialThrombocythemia #myelofibrosis #bomedemstat #LSD1 #BloodCancer #RareDisease ImagoBio.com Download the transcript    

  • Remote Patient Monitoring Virtual Visits Driving Reduction in Hospital Readmissions with Eric Rock Vivify Health TRANSCRIPT
    on September 9, 2021 by Karen Jagoda

    Eric Rock is the Founder and CEO of Vivify Health and a pioneer in the application of remote patient monitoring, consumer electronics, and biometric devices combined with virtual visits to connect patients and providers outside the hospital setting. Eric explains, "Fortunately, Vivify, from our beginning days, created a solution that encompassed a connected tablet with a very unique and simple experience that spoke to the patient and connected to the provider. It made it incredibly simple regardless of your age. With an average age of 77 across our customer base, where that product was applied to, we knew this market well. And many were entering the market saying, "Okay, well, I can just give them an app to download." Well, that's a very quick failure in that population." "So, understanding the complexities of distributing devices to patients that we're all responsible for and even getting those devices returned in most cases is a big part of the services and value that Vivify brings to the table. So it is a very simple solution for seniors with all of that backend technology support logistics, and an incredible experience for the provider as well. It's simple for everybody involved as it would be for an in-person visit, while at the same time we manage all of that technology headache. And we've done that very well for over a decade." @VivifyHealth @ericlrock #DigitalHealth #telehealth #telemedicine #remotepatientmonitoring #RPM #VirtualHealthcare VivifyHealth.com Listen to the podcast here

Related Post

NEWSLETTER

Sign up for Breaking News, Newsletter, Blog Posts and Special Deals from 1631 Digital and their media/marketing partners.

Subscribers agree to be contacted from 1631 Digital News and/or their media/marketing partners for breaking news alerts, newsletters and special media marketing offers via email, mail and/or texting communication.